Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Microdose Psychedelic Insights

DARK SECRETS: The trials and tribulations of psychedelic research | Vintage Vibes

This article by Natasha Sumner was originally published on Microdose and appears here with permission.

A growing body of research into the therapeutic use of psychedelics, including — MDMA, psilocybin, LSD, ketamine, and DMT, are delivering promising results to treat a wide range of conditions such as post-traumatic stress disorder (PTSD), depression, end-of-life anxiety, eating disorders, stroke, and chronic pain. Robin Carhart-Harris, head of the Centre for Psychedelic Research at Imperial College London, wrote for The Guardian, “we can no longer ignore the potential of psychedelic drugs…psychedelics appear to increase brain ‘plasticity,’ which, broadly speaking, implies an accelerated ability to change.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.